Background
Vaginal self-sampling (VSS) has been implemented as the primary cervical cancer screening tool in several countries around the world. Urine collection (UC) can be an alternative if women are uncomfortable with genital sampling. Women living with HIV (WLHIV) are at increased risk of cervical intraepithelial lesions.
Methods
AUTOCol is a multicentre prospective study enrolling WLHIV for cervical cancer screening in 4 hospitals from COREVIH IDF Nord. Both VSS (FLOQSwab in Mswab medium, Copan, Italy) and UC (Colli-pee, Novosanis, Belgium) were offered. High-risk human papillomavirus (HR-HPV) were detected with AnyplexII (Seegene, South Korea) by semi-quantitative PCR.
Results
Between June 2023 and January 2024, 201 WLHIV with a median age of 51 years (IQR=43-58) were enrolled in the study. Among the 199 WLHIV with available HIV viral load (VL), 91% (n=182) were undetectable (<50 c/mL). Median CD4 T-cell count was 770/mm3 (IQR=560-990) with 5 WLHIV <200/mm3. The acceptance rate to carry out self-sampling was 87% (n=175). The main reason for refusal was the fear of failing (n=14/26). Patients felt no pain during the UC in 98% of cases (n=156/160) compared to 83% of cases for the VSS (n=140/169), which was uncomfortable for 10% of patients (n=17/169). Patients preferred the UC (n=129/162, 80%) and the VSS (n=128/173, 74%) to the cervical smear performed by a health professional.
A total of 174 VSS and 169 UC were collected resulting in 167-paired samples. Both VSS and UC were suitable for HPV detection, with only one unsatisfactory sample in each. On VSS, 75 WLHIV (43%) harbored at least one HR-HPV and of these, 33% (n=25) had multiple infections. HPV68 was the most prevalent type (n=18/174, 10%) and 5% of WLHIV (n=8/174) were positive for HPV16.
VSS and UC HR-HPV results showed good agreement (83%, kappa=0.64). Regarding discrepancies between paired samples, 39 HR-HPV from 34 WLHIV were detected in VSS and negative in UC while only 8 HR-HPV in 7 WLHIV were positive in UC and negative in VSS (Fig.1). HR-HPV VL estimation was low for 37 of these 47 discordant HR-HPV (79%).
Conclusions
VSS and UC are well accepted by patients and preferred to cervical smear. They are both suitable for HR-HPV detection, but VSS appears to be more sensitive when HR-HPV VL is low. VSS is a good alternative for women who need frequent cervical cancer screening or are reluctant to undergo gynecological examination. UC should only be proposed if women refuse any genital sampling.
Table or Figure
![]()